Metal-based anticancer agents /
Metal-based Anticancer Agents covers the interdisciplinary world of inorganic drug discovery and development by introducing the most prominent compound classes based on different transition metals, discussing emerging concepts, enabling methods, and key pre-clinical and clinical aspects.
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cambridge :
Royal Society of Chemistry,
2019.
|
| Series: | RSC metallobiology series ;
14. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Enhancing the Therapeutic Potential of Platinum-Based Anti-Cancer Agents by Incorporating Clinically Approved Drugs as Ligands; Ruthenium, Osmium and Iridium in the fight against cancer; Iron compounds as anticancer agents; Recent advances in anticancer copper compounds; Anticancer Gold Compounds; Heterometallic Complexes as Anticancer Agents; Vanadium Compounds as enzyme inhibitors with a focus on anticancer effects; Arsenic-based Anticancer Agents; Supramolecular metal-based structures for applications in cancer therapy; 2 Enabling Methods to Elucidate the Effects of Metal-based Anticancer Agents; Metal-Based Radiotherapeutics; Challenges and Chances in the Pre-clinical to Clinical Translation of Anticancer Metallodrugs